2020-2027 Analysis and Review Functional Dyspepsia Drug Market

Functional Dyspepsia Drug Market

Functional Dyspepsia Drug Market By Treatment Regimen (Acid Suppression Therapy, Prokinetic Agents, Antidepressants and Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027

18-05-2020 REP-HC-5089 40 Tables 115 pages Format

The functional dyspepsia drug market was valued at USD 1,500.3 Mn by 2019. The rising prevalence of indigestion encountered in the adult population worldwide primarily determines the functional dyspepsia drug market growth. Effective diagnosis followed by prescription of accurate treatment regimen further accentuates the functional dyspepsia drug market growth.

Functional Dyspepsia Drug Market


Functional dyspepsia is recognized by the clinical manifestations such as bloating of the stomach, excessive belching, heartburn, nausea, epigastric pain, etc. The major causes associated with the occurrence of functional dyspepsia throughout the globe are smoking and alcohol consumption, craving for spicy food, stress, and anxiety, etc.

The major segments related to the functional dyspepsia drug market are: 

By Treatment Regimen (2017–2027; US$ Mn)

Acid Suppression Therapy

Prokinetic Agents

Antidepressants

Others

By Distribution Channel (2017–2027; US$ Mn)

Hospital Pharmacy

Retail Pharmacy

Others

Geography Segment (2017–2027; US$ Mn)

North America

U.S.
Canada

Europe

United Kingdom
Germany
Russia
France
Italy
Spain
Ukraine
Rest of Europe

Asia Pacific

China
Japan
Rest of Asia Pacific

Latin America (LATAM)

Brazil
Mexico
Rest of Latin America

Middle East and Africa (MEA)

GCC
Rest of MEA 

Justification for study?

  • The intention of the study is to give a comprehensive outlook of the global functional dyspepsia drug market
  • The overall segmentation of the functional dyspepsia drug market, by treatment regimen, distribution channel, and geography is minutely studied. Acid suppression therapy and hospital pharmacy are dominating the Treatment Regimen and distribution channel segments respectively
  • Significant increase in the number of people suffering from functional dyspepsia worldwide
  • Numerous clinical trial investigation conducted for determining the low dose of antidepressant in achieving abdominal pain relief due to functional dyspepsia

Report gist?

  • The study of the global functional dyspepsia drug market includes qualitative analysis of factors such as drivers, restraints, and opportunities
  • The report covers qualitative and quantitative analysis of the overall market segmented on the basis of treatment regimen and distribution channel and categorization of the same at geography level
  • This research report presents the analysis of each segment from 2017 to 2027 in which 2019 is considered as the base year. Compounded annual growth rate is calculated for the respective segments from 2020 to 2027

The study includes the profiles of major market players with a significant global and regional presence along with top company positioning. 

Significant customers?

  • This study is suitable for industry participants and stakeholders in the pharmaceutical manufacturers actively engaged in the production and marketing of functional dyspepsia drugs due to the rising prevalence of indigestion among the adult population worldwide
  • The report will benefit physicians engaged in the prescription of drugs for the treatment of functional dyspepsia
  • Managers with financial institutions looking to publish recent and forecasted statistics pertaining to functional dyspepsia drug market
  • Financial institutions, venture capitalist, analysts, investors, government organizations, policymakers, regulatory authorities, researchers, looking for insights into the market to determine future strategies 

Segment Analysis

Acid suppressant therapy is holding the largest market share in the treatment regimen segment for the functional dyspepsia drug market. It is the first-line therapy that comprises of drugs such as omeprazole, lansoprazole, pantoprazole, etc. are prescribed to neutralize the excessive acid produced in the stomach and need to be taken half an hour prior to any major meal. Prokinetic agents such as metoclopramide and domperidone are prescribed on account of early gastric emptying by stimulating the digestive tract motility. Antidepressants are expected to register the fastest market growth in the near future on account of its ability to relieve epigastric pain with improved gastric accommodation and postprandial symptoms. Herbal therapies have also garnered huge attraction worldwide for e.g. Iberogast has been useful in treating functional dyspepsia as it is a mixture of plant herbs having carminative, local anesthetic, and peristalsis regulating properties.

Hospital pharmacy is currently dominating the distribution channel segment for functional dyspepsia market. Acid suppressants and Prokinetic agents are associated with severe side effects, hence it is necessary for the hospital pharmacist to precisely compound the medicines to prevent the occurrence of any side effects. Retail pharmacy is gaining tremendous demand as a sales channel in the developing regions on account of government-sponsored generic drug retail outlets to cater to the medical requirement of low-income populations.

North America is presently leading the geography segment for the functional dyspepsia drug market. The rising prevalence of indigestion primarily drives the functional dyspepsia drug market growth in the region. As per the latest research citings presented by the National Institute of Health (NIH), functional dyspepsia occurs in every 3 in 4 people suffering from indigestion in the United States. Increasing consumption of caffeinated beverages, alcohol, tobacco, junk food, etc. are the major causative agents responsible for the occurrence of functional dyspepsia in the region. Europe is regarded as the second-largest regional segment for the functional dyspepsia drug market. Effective implementation of treatment guidelines pertaining to functional dyspepsia determines the market growth in the region. Asia Pacific is anticipated to be the fastest-growing segment during the forecast period, owing to the daily intake of spicy food which forms an inherent part of the culinary customs and traditions prevalent in the region. Furthermore, the presence of a well-developed generic drug market further propels its market growth in the Asia Pacific region.

Select License Type

$4,600
$6,600
$13,200

Safe and Secure SSL Encrypted

Have a Question?

We will help you find what you are looking for.

Call 1-518-730-1560

Contact sales

How can we help you?

Get in touch with us or find an office closest to you.